4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Quince Therapeutics, Inc. (QNCX) operates in the Biotechnology industry and is headquartered in South San Francisco, United States with about 38 employees. Its market capitalization is roughly $17 million. In the fiscal year ended 2025-12-31, QNCX reported $0M in revenue and ($84M) in net income.
Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($50M) | ($36M) | ($27M) | ($51M) |
| Net Income | ($84M) | ($57M) | ($31M) | ($52M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($11M) | ($16M) | ($11M) | ($10M) | ($13M) |
| Net Income | $36M | ($40M) | ($13M) | ($16M) | ($15M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $94M | $114M | $168M | $104M | — |
| Total Liabilities | $129M | $84M | $83M | $3M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive QNCX viewer.
About TickerBase · Data methodology & sources